Teplizumab

1 Drug classified under this active ingredient

anti-CD3, Monoclonal Antibody. Teplizumab 1 mg/ml.
conc. for sol. for IV infus. 1/10/ 14 X 2 mg/ml
Dosage based on body surf. Day 1: 65 mcg/m² / Day 2: 125 mcg/m² /
Day 3: 250 mcg/m² / Day 4: 500 mcg/m² / Days 5 through 14: 1,030 mcg/m². See full prescription info.
To delay onset of Stage 3 type 1 diabetes in adlts and ped. pts > 8 years of age with Stage 2 type 1 diabetes
.C/I:  Hypersens